This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) to develop best practices for the safe and effective use of artificial intelligence (AI) and machine learning (ML) systems and digitally-derived measures that matter to patients. Food and Drug Administration.
DUBLIN–(BUSINESS WIRE)–The “Global DigitalHealth Market Report and Forecast 2023-2031” report has been added to ResearchAndMarkets.com’s offering. The global digitalhealth market value in 2022 was USD 227.5 billion driven by the rising demand for remote healthcare services across the globe.
Exec Summary: The HealthTech sector is poised for significant M&A activity in 2025, driven by several key trends: DigitalHealth Solutions: The increasing demand for digitalhealth solutions to improve healthcare accessibility and efficiency will drive acquisitions of innovative startups and established players in this space.
–(BUSINESS WIRE)–AstraZeneca today launches Evinova, set to be a leading provider of digitalhealth solutions to better meet the needs of healthcare professionals, regulators and patients. 2 Digitalhealth is a large (+$900bn by 2032) and growing (13.6% CAGR 2022-2032) market.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content